Relevant impact of central pathology review on nodal classification in individual breast cancer patients (English)
- New search for: Vestjens, J. H.
- New search for: Pepels, M. J.
- New search for: de Boer, M.
- New search for: Borm, G. F.
- New search for: van Deurzen, C. H.
- New search for: van Diest, P. J.
- New search for: van Dijck, J. A.
- New search for: Adang, E. M.
- New search for: Nortier, J. W.
- New search for: Rutgers, E. J.
- New search for: Vestjens, J. H.
- New search for: Pepels, M. J.
- New search for: de Boer, M.
- New search for: Borm, G. F.
- New search for: van Deurzen, C. H.
- New search for: van Diest, P. J.
- New search for: van Dijck, J. A.
- New search for: Adang, E. M.
- New search for: Nortier, J. W.
- New search for: Rutgers, E. J.
In:
ANNALS OF ONCOLOGY
;
23
, 10
;
2561-2566
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Relevant impact of central pathology review on nodal classification in individual breast cancer patients
-
Contributors:Vestjens, J. H. ( author ) / Pepels, M. J. ( author ) / de Boer, M. ( author ) / Borm, G. F. ( author ) / van Deurzen, C. H. ( author ) / van Diest, P. J. ( author ) / van Dijck, J. A. ( author ) / Adang, E. M. ( author ) / Nortier, J. W. ( author ) / Rutgers, E. J. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 10 ; 2561-2566
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 10
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 2473
-
Novel therapies for advanced prostate cancer: have we have widened the goal posts too far?Raghavan, D. et al. | 2012
- 2475
-
Cognitive complaints in women with breast cancer: cross-cultural considerationsRibi, K. et al. | 2012
- 2479
-
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingSchmoll, H. J. / Van Cutsem, E. / Stein, A. / Valentini, V. / Glimelius, B. / Haustermans, K. / Nordlinger, B. / van de Velde, C. J. / Balmana, J. / Regula, J. et al. | 2012
- 2517
-
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?Glynne-Jones, R. / Anyamene, N. / Moran, B. / Harrison, M. et al. | 2012
- 2526
-
mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directionsVillarreal-Garza, C. / Cortes, J. / Andre, F. / Verma, S. et al. | 2012
- 2536
-
Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studiesAune, D. / Chan, D. S. / Vieira, A. R. / Navarro Rosenblatt, D. A. / Vieira, R. / Greenwood, D. C. / Cade, J. E. / Burley, V. J. / Norat, T. et al. | 2012
- 2547
-
Cognitive changes in multiethnic Asian breast cancer patients: a focus group studyCheung, Y. T. / Shwe, M. / Tan, Y. P. / Fan, G. / Ng, R. / Chan, A. et al. | 2012
- 2552
-
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trialLadoire, S. / Mignot, G. / Dalban, C. / Chevriaux, A. / Arnould, L. / Rebe, C. / Apetoh, L. / Boidot, R. / Penault-Llorca, F. / Fumoleau, P. et al. | 2012
- 2561
-
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsVestjens, J. H. / Pepels, M. J. / de Boer, M. / Borm, G. F. / van Deurzen, C. H. / van Diest, P. J. / van Dijck, J. A. / Adang, E. M. / Nortier, J. W. / Rutgers, E. J. et al. | 2012
- 2566
-
Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAMHadji, P. / Kieback, D. G. / Tams, J. / Hasenburg, A. / Ziller, M. et al. | 2012
- 2572
-
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypesHumbert, O. / Berriolo-Riedinger, A. / Riedinger, J. M. / Coudert, B. / Arnould, L. / Cochet, A. / Loustalot, C. / Fumoleau, P. / Brunotte, F. et al. | 2012
- 2578
-
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersBrouckaert, O. / Laenen, A. / Vanderhaegen, J. / Wildiers, H. / Leunen, K. / Amant, F. / Berteloot, P. / Smeets, A. / Paridaens, R. / Christiaens, M. R. et al. | 2012
- 2585
-
Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastasesde Boer, M. / Adang, E. M. / Van Dycke, K. C. / van Dijck, J. A. / Borm, G. F. / Seferina, S. C. / van Deurzen, C. H. / van Diest, P. J. / Bult, P. / Donders, A. R. et al. | 2012
- 2591
-
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC `boost versus no boost' trialImmink, J. M. / Putter, H. / Bartelink, H. / Cardoso, J. S. / Cardoso, M. J. / van der Hulst-Vijgen, M. H. / Noordijk, E. M. / Poortmans, P. M. / Rodenhuis, C. C. / Struikmans, H. et al. | 2012
- 2599
-
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II studyCollea, R. P. / Kruter, F. W. / Cantrell, J. E. / George, T. K. / Kruger, S. / Favret, A. M. / Lindquist, D. L. / Melnyk, A. M. / Pluenneke, R. E. / Shao, S. H. et al. | 2012
- 2605
-
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapyHanker, L. C. / Loibl, S. / Burchardi, N. / Pfisterer, J. / Meier, W. / Pujade-Lauraine, E. / Ray-Coquard, I. / Sehouli, J. / Harter, P. / du Bois, A. et al. | 2012
- 2613
-
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTGLindemann, K. / Christensen, R. D. / Vergote, I. / Stuart, G. / Izquierdo, M. A. / Kaern, J. / Havsteen, H. / Eisenhauer, E. / Ridderheim, M. / Lopez, A. B. et al. | 2012
- 2619
-
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)Ruers, T. / Punt, C. / Van Coevorden, F. / Pierie, J. P. / Borel-Rinkes, I. / Ledermann, J. A. / Poston, G. / Bechstein, W. / Lentz, M. A. / Mauer, M. et al. | 2012
- 2627
-
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancerSchou, J. V. / Larsen, F. O. / Rasch, L. / Linnemann, D. / Langhoff, J. / Hogdall, E. / Nielsen, D. L. / Vistisen, K. / Fromm, A. / Jensen, B. V. et al. | 2012
- 2633
-
An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancerVoskoboynik, M. / Bae, S. / Ananda, S. / Desai, J. / Kosmider, S. / Gibbs, P. et al. | 2012
- 2638
-
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancerAjani, J. A. / Correa, A. M. / Hofstetter, W. L. / Rice, D. C. / Blum, M. A. / Suzuki, A. / Taketa, T. / Welsh, J. / Lin, S. H. / Lee, J. H. et al. | 2012
- 2642
-
Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinomavan der Gaag, N. A. / Kloek, J. J. / de Bakker, J. K. / Musters, B. / Geskus, R. B. / Busch, O. R. / Bosma, A. / Gouma, D. J. / van Gulik, T. M. et al. | 2012
- 2649
-
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic modelSalah, S. / Watanabe, K. / Welter, S. / Park, J. S. / Park, J. W. / Zabaleta, J. / Ardissone, F. / Kim, J. / Riquet, M. / Nojiri, K. et al. | 2012
- 2656
-
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysisJanjigian, Y. Y. / Werner, D. / Pauligk, C. / Steinmetz, K. / Kelsen, D. P. / Jager, E. / Altmannsberger, H. M. / Robinson, E. / Tafe, L. J. / Tang, L. H. et al. | 2012
- 2663
-
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkersSeront, E. / Rottey, S. / Sautois, B. / Kerger, J. / DHondt, L. A. / Verschaeve, V. / Canon, J. L. / Dopchie, C. / Vandenbulcke, J. M. / Whenham, N. et al. | 2012
- 2670
-
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up studyKasenda, B. / Schorb, E. / Fritsch, K. / Finke, J. / Illerhaus, G. et al. | 2012
- 2676
-
Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphomaStevens, W. B. / van Krieken, J. H. / Mus, R. D. / Arens, A. I. / Mattijssen, V. / Oosterveld, M. / de Kruijf, E. J. / de Vries, F. / Koster, A. / van der Maazen, R. et al. | 2012
- 2681
-
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapyTerpos, E. / Kastritis, E. / Christoulas, D. / Gkotzamanidou, M. / Eleutherakis-Papaiakovou, E. / Kanellias, N. / Papatheodorou, A. / Dimopoulos, M. A. et al. | 2012
- 2687
-
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphomaMorschhauser, F. / Recher, C. / Milpied, N. / Gressin, R. / Salles, G. / Brice, P. / Vey, N. / Haioun, C. / Colombat, P. / Rossi, J. F. et al. | 2012
- 2695
-
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceLe Gouill, S. / Kroger, N. / Dhedin, N. / Nagler, A. / Bouabdallah, K. / Yakoub-Agha, I. / Kanouni, T. / Bulabois, C. E. / Tournilhac, O. / Buzyn, A. et al. | 2012
- 2703
-
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysisAhn, H. K. / Suh, C. / Chuang, S. S. / Suzumiya, J. / Ko, Y. H. / Kim, S. J. / Huh, J. R. / Yoon, D. H. / Oh, S. Y. / Kim, J. S. et al. | 2012
- 2708
-
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891Lefebvre, J. L. / Andry, G. / Chevalier, D. / Luboinski, B. / Collette, L. / Traissac, L. / de Raucourt, D. / Langendijk, J. A. et al. | 2012
- 2714
-
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancerMorris, M. J. / Eisenberger, M. A. / Pili, R. / Denmeade, S. R. / Rathkopf, D. / Slovin, S. F. / Farrelly, J. / Chudow, J. J. / Vincent, M. / Scher, H. I. et al. | 2012
- 2720
-
Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?Hemminki, K. / Bevier, M. / Sundquist, J. / Hemminki, A. et al. | 2012
- 2725
-
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP casesGolfinopoulos, V. / Pentheroudakis, G. / Goussia, A. / Siozopoulou, V. / Bobos, M. / Krikelis, D. / Cervantes, A. / Ciuleanu, T. / Marselos, M. / Fountzilas, G. et al. | 2012
- 2731
-
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgeryYun, Y. H. / Kim, Y. A. / Min, Y. H. / Park, S. / Won, Y. J. / Kim, D. Y. / Choi, I. J. / Kim, Y. W. / Park, S. J. / Kim, J. H. et al. | 2012
- 2737
-
Dietary folates and cancer risk in a network of case-control studiesTavani, A. / Malerba, S. / Pelucchi, C. / Dal Maso, L. / Zucchetto, A. / Serraino, D. / Levi, F. / Montella, M. / Franceschi, S. / Zambon, A. et al. | 2012
- 2743
-
Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the NetherlandsHaasbeek, C. J. / Palma, D. / Visser, O. / Lagerwaard, F. J. / Slotman, B. / Senan, S. et al. | 2012
- 2748
-
Geographic distribution of hematopoietic cancers in the Nile delta of EgyptHerzog, C. M. / Dey, S. / Hablas, A. / Khaled, H. M. / Seifeldin, I. A. / Ramadan, M. / El-Hamzawy, H. / Wilson, M. L. / Soliman, A. S. et al. | 2012
- 2755
-
Trends in cancer mortality in China: an updateGuo, P. / Huang, Z. L. / Yu, P. / Li, K. et al. | 2012
- 2763
-
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyLeahy, M. / Garcia del Muro, X. / Reichardt, P. / Judson, I. / Staddon, A. / Verweij, J. / Baffoe-Bonnie, A. / Jonsson, L. / Musayev, A. / Justo, N. et al. | 2012
- 2771
-
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306Pietrantonio, F. / Garassino, M. C. / Torri, V. / de Braud, F. et al. | 2012
- 2772
-
Association of telomerase expression with recurrence of sacral chordomaHu, H. / Yang, H. L. / Lu, J. / Chen, K. W. / Qiu, Y. H. / Liu, W. / Luo, Z. P. et al. | 2012
- 2773
-
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)| 2012